Bracciale, Laura
 Distribuzione geografica
Continente #
EU - Europa 845
NA - Nord America 845
AS - Asia 270
AF - Africa 5
OC - Oceania 1
Totale 1.966
Nazione #
US - Stati Uniti d'America 843
DE - Germania 344
CN - Cina 147
SE - Svezia 128
UA - Ucraina 104
FR - Francia 88
SG - Singapore 52
IE - Irlanda 39
PL - Polonia 35
IT - Italia 31
GB - Regno Unito 27
IN - India 26
FI - Finlandia 21
ID - Indonesia 21
TR - Turchia 15
RU - Federazione Russa 12
CH - Svizzera 4
IR - Iran 3
NL - Olanda 3
CA - Canada 2
EG - Egitto 2
ES - Italia 2
HK - Hong Kong 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
BE - Belgio 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
IS - Islanda 1
JP - Giappone 1
KE - Kenya 1
NZ - Nuova Zelanda 1
RO - Romania 1
UG - Uganda 1
VN - Vietnam 1
Totale 1.966
Città #
Chandler 186
Ashburn 83
Jacksonville 65
San Mateo 45
New York 43
Dublin 36
Singapore 36
Kraków 35
Dearborn 32
Nanjing 32
Houston 24
Wilmington 23
Bremen 21
Jakarta 21
Nanchang 20
Nürnberg 20
Ann Arbor 18
Lawrence 18
Seattle 16
Izmir 15
Woodbridge 14
Shenyang 12
Moscow 10
Boardman 9
Detroit 9
Kunming 9
Munich 9
Redwood City 9
Verona 9
Hebei 8
Milan 8
University Park 8
Boston 7
Changsha 7
Fairfield 7
Lancaster 7
Leawood 7
Hangzhou 6
Tianjin 6
Cambridge 5
Hefei 5
Mountain View 5
Fremont 4
Jinan 4
Philadelphia 4
Princeton 4
Rome 4
Beijing 3
Changchun 3
Guangzhou 3
Los Angeles 3
Norwalk 3
San Francisco 3
Santa Clara 3
Simi Valley 3
Andover 2
Barcelona 2
Berlin 2
Costa Mesa 2
Falls Church 2
Hong Kong 2
Indiana 2
Jiaxing 2
Shanghai 2
Siena 2
Tappahannock 2
Vientiane 2
Washington 2
Abidjan 1
Amsterdam 1
Auckland 1
Augusta 1
Brussels 1
Cattolica 1
Collegeville 1
Frankfurt am Main 1
Fuzhou 1
Hounslow 1
Kashan 1
Kish 1
La Canada Flintridge 1
Las Vegas 1
London 1
Marseille 1
Mcallen 1
Miami 1
Mumbai 1
New Delhi 1
Ottawa 1
Petriolo 1
Prague 1
Saint Louis 1
Toronto 1
Wuhan 1
Zanjan 1
Zhengzhou 1
Zurich 1
Totale 1.064
Nome #
Relationship between antiretroviral plasma concentration and emergence of HIV-1 resistance mutations at treatment failure 129
Cardiovascular risk score change in HIV-1-infected patients switched to an atazanavir-based combination antiretroviral regimen. 122
Darunavir/ritonavir and raltegravir coadministered in routine clinical practice: potential role for an unexpected drug interaction 109
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 108
Predictors of successful genotype-guided antiretroviral therapy in treatment-experienced individuals over calendar year: a cohort study 106
The effect of polymorphisms in candidate genes on the long-term risk of lipodystrophy and dyslipidemia in HIV-infected white patients starting antiretroviral therapy 106
Pharmacokinetic variability of antiretroviral drugs and correlation with virological outcome: two years experience in routine clinical practice 102
Are mutations in HIV type-1 reverse transcriptase 245 codon predictive of abacavir hypersensitivity reaction? 98
Virological suppression reduces clinical progression in patients with multiclass-resistant HIV type 1 98
Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients 97
Decreased plasma levels of darunavir/ritonavir in a vertically infected pregnant woman carrying multiclass-resistant HIV type-1 95
Serological response to hepatitis B virus vaccine in HIV-infected children in Tanzania 91
Declining prevalence of HIV-1 drug resistance in treatment-failing patients: a clinical cohort study. 90
Mitochondrial DNA haplogroups and incidence of lipodystrophy in HIV-infected patients on long-term antiretroviral therapy 88
Prevalence of transmitted HIV-1 drug resistance in HIV-1 infected patients in Italy: evolution over 12 years and predictors 83
Tenofovir discontinuation could predispose to urolithiasis in atazanavir-treated patients 82
Comparative determination of HIV-1 co-receptor tropism by Enhanced Sensitivity Trofile, gp120 V3-loop RNA and DNA genotyping 80
Long term follow-up of Nevirapine-treated patients in a single centre cohort 79
Lipid-lowering effect of tenofovir in HIV-infected patients 79
The threshold bootstrap clustering: a new approach to find families or transmission clusters within molecular quasispecies 77
Resistance considerations in sequencing of antiretroviral therapy in low-middle income countries with currently available options 53
Totale 1.972
Categoria #
all - tutte 6.879
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.879


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020160 0 0 0 0 23 40 15 7 14 30 6 25
2020/2021226 7 21 10 23 24 23 34 3 32 7 39 3
2021/2022193 30 24 4 7 7 11 1 27 4 18 30 30
2022/2023453 50 69 35 85 37 63 12 32 54 1 13 2
2023/2024215 9 57 2 21 10 59 5 0 2 4 39 7
2024/202596 8 9 24 14 41 0 0 0 0 0 0 0
Totale 1.972